Ocular allergy: Diagnosis and treatment

Ophthalmology Clinics of North America

Volumn 18, Issue 4, 2005, Pages 485-492

  Butrus, Salim ^a   Portela, Rosaliz ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTAZOLINE; ANTIHISTAMINIC AGENT; AZELASTINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOSPORIN; DECONGESTIVE AGENT; DEXAMETHASONE SODIUM PHOSPHATE; EMADASTADINE DIFURAMATE; EPINASTINE; HYDROCORTISONE SODIUM SUCCINATE; KETOROLAC; KETOTIFEN; KETOTIFEN FUMARATE; LEVOCABASTINE; LODOXAMIDE TROMETAMOL; LOTEPREDNOL; NAPHAZOLINE; NEDOCROMIL; NEDOCROMIL SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; OLOPATADINE; PEMIROLAST; PHENIRAMINE; RIMEXOLONE; STABILIZING AGENT; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOCONSTRICTOR AGENT;

ATOPIC KERATOCONJUNCTIVITIS; BURNING SENSATION; CATARACT; CLINICAL TRIAL; CORNEA DISEASE; CORNEAL MELTING; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DROWSINESS; DRUG INSTILLATION; DRUG SENSITIVITY; DRY EYE; GLAUCOMA; HUMAN; HYPERSENSITIVITY; OCULAR ALLERGY; PATHOPHYSIOLOGY; PERENNIAL ALLERGIC CONJUNCTIVITIS; PRIORITY JOURNAL; REBOUND CONGESTION; REVIEW; SEASONAL ALLERGIC CONJUNCTIVITIS; SIDE EFFECT; STINGING SENSATION; SUPERINFECTION; VERNAL CONJUNCTIVITIS;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONJUNCTIVITIS, ALLERGIC; DIAGNOSIS, DIFFERENTIAL; HISTAMINE H1 ANTAGONISTS; HUMANS; TREATMENT OUTCOME;

EID: 28444455278     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ohc.2005.07.007     Document Type: Review

References (21)

1. T. John Eosinophils M.B. Abelson Allergic diseases of the eye 2000 WB Saunders Co. Philadelphia 33 41
2. R.B. Coutu Treatment of vernal keratoconjunctivitis: a retrospective clinical case study Optom Vis Sci 68 7 1991 561 564
3. S. Singh, V. Pal, and C.S. Dhull Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis Indian J Ophthalmol 49 4 2001 241 245
4. J.S. Saini, A. Gupta, and S.K. Pandey Efficacy of supratarsal dexamethasone versus triamcinolone injection in recalcitrant vernal keratoconjunctivitis Acta Ophthalmol Scand 77 5 1999 515 518
5. M.B. Abelson, and M.R. Allensmith Histamine in the eye A. Silverstein G. O'Connor Immunology and immunopathology of the eye 1979 Masson Publishing New York 362 364
6. M.B. Abelson, A. Leonardi, and L. Smith The mechanisms, diagnosis and treatment of allergy Rev Ophthalmol 9 4 2003 74 84
7. J.M. Nevius, M.B. Abelson, and D. Welch The ocular drying effect of oral antihistamines (loratadine) in the normal population-an evaluation Invest Ophthalmol Vis Sci 40 Suppl 1999 S549
8. J.H. Crampton Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double masked, placebo- and active-controlled trial Clin Ther 25 2003 1975 1987
9. M.B. Abelson Randomized double blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis Clin Ther 25 3 2003 931 947
10. M.B. Abelson, S. Pratt, and J. Mussoline One-visit, randomized, placebo-controlled conjunctiva allergen challenge study scanning and imaging technology for objective quantification of eyelid swelling in the allergic reaction with the contralateral use of olopatadine and artificial tears Clin Ther 25 7 2003 2070 2084
11. M.B. Abelson Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model Curr Med Res Opin 20 12 2004 1953 1958
12. B.Q. Lanier, I. Finegold, and P. D'Arienzo Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model Curr Med Res Opin 20 8 2004 1227 1233
13. G.J. Berdy, D.L. Spangler, and G. Bensch A comparison of the relative efficacy and the clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model Clin Ther 22 2000 826 833
14. V. Yaylali, I. Demirlenk, and S. Tatlipinar Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis Acta Ophthalmol Scand 81 4 2003 378 382
15. D. Spangler, G. Bensch, and G. Berdy Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge study Clin Ther 23 8 2001 1272 1279
16. B.Q. Lanier, I. Finegold, and P. D'Arienzo The clinical efficacy of olopatadine hydrochloride 0.1% ophthalmic solution compared with epinastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model Current Medical Research Opinion 20 8 2004 1227 1233
17. W.H. Rooks, V.P.J. Maloney, and L.D. Shott Clinical evaluation of ketorolac tromethamine 0.5% in patients with acute seasonal allergic conjunctivitis Invest Ophthalmol Vis Sci 35 1994 180
18. M.B. Abelson, S.I. Butrus, and J.H. Weston Aspirin therapy in vernal conjunctivitis Am J Ophthalmol 95 1983 502 505
19. E. Meyer, E. Kraus, and Z. Zonis Efficacy of antiprostaglandin therapy for vernal conjunctivitis Br J Ophthalmol 71 1987 497 499
20. E. Holland Ocular allergic disease: mechanisms, disease subtypes, treatment Ocul Surf 1 3 2003 38 60
21. M.B. Abelson, and M. Chapin Current and future topical treatments for ocular allergy Comp Ophthalmol Update 1 5 2000 303 320